<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02382744</url>
  </required_header>
  <id_info>
    <org_study_id>H14-02912</org_study_id>
    <nct_id>NCT02382744</nct_id>
  </id_info>
  <brief_title>Saphenous Nerve Block for Foot and Ankle Surgery</brief_title>
  <official_title>A Comparison of Ultrasound-Guided and Ultrasound-Guided With Nerve Stimulation Saphenous Nerve Blockade Utilizing the Transsartorial Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing foot and ankle surgery have the option of having a nerve block
      administered by their Anesthesiologist. The nerve block numbs the foot and results in less
      post-operative nausea and vomiting, and better pain control. Two different techniques for
      blocking the saphenous nerve to the foot have been described and are both commonly used at
      St. Paul's hospital. The goal of this study is to compare the success rates of these two
      techniques.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose / Hypothesis This clinical study is a prospective, controlled, randomized,
      single-blinded trial designed to investigate the hypothesis that ultrasound-guided blockade
      of the saphenous nerve in conjunction with nerve stimulation has a higher success rate when
      compared to ultrasound alone. These research interventions represent what is considered to be
      an improvement on the standard practice at St. Paul's, which is to block the saphenous nerve
      with one of any number of saphenous nerve blocks, using a number of different techniques
      (i.e. ultrasound-guided, nerve stimulation, blind field block); the effectiveness of which
      has been inconsistent. The purpose of this study is to identify if one technique has a great
      success rate over another, which would ultimately result in increased success rates of
      saphenous nerve blocks and patient care.

      Study Design The study will be a randomized, single-blinded trial of 80 subjects who are
      undergoing foot and ankle surgery. Informed consent will be obtained from all study subjects.
      Subjects will be randomized to one of two saphenous nerve block techniques to be administered
      by an experienced regional anesthesiologist at St. Paul's Hospital. Once the nerve block is
      completed the success will be evaluated by an investigator blinded to the procedure. Once the
      30min evaluation is completed anesthetic care will be provided according to regular
      institutional practice and at the discretion of the attending anesthesiologist. The subject
      will then be contacted at 2 and 7 days after block administration to assess for delayed
      complications.

      Intravenous access will be gained and non-invasive blood pressure measurements will be
      recorded every five minutes. Continuous electrocardiography and oxygen saturation monitoring
      will be maintained throughout the procedure and for at least 60 minutes afterwards. Light
      sedation will be provided, with the goal of maintaining verbal contact with the subject
      throughout the procedure. Where clinically appropriate, the study block may be preceded by an
      ultrasound-guided popliteal sciatic nerve block at the discretion of the attending
      anesthesiologist.

      Saphenous nerve blockade will be preformed using a transsartorial approach. Subjects in both
      groups will be positioned prone. The ultrasound probe will be placed in the transverse plane
      on the medial aspect of the thigh 3-5cm cephalad to the superior border of the patella (area
      marked). An attempt will then be made to identify the saphenous nerve, which runs deep to the
      sartorius muscle within the subsartorial fascial plane. The nerve will appear hyperechoic,
      round or oval shaped. The anesthesiologist will have a maximum scan time of 3 minutes prior
      to needle entry. Up to 5 mL of 1% Lidocaine will be used for skin infiltration of the
      injection site. The block will then be preformed as to the protocols below depending on group
      allocation. A thirty minute evaluation of the saphenous nerve block will occur during the
      normal monitoring period after the placement of a block.

      Following completion of the thirty-minute evaluation, anesthetic care will be provided
      according to regular institutional practice and at the discretion of the attending
      anesthesiologist. This may include spinal or general anesthesia.

      All subjects will be contacted by telephone at two and seven days post procedure for a follow
      up interview to assess for delayed complications associated with the procedure.

      The medications used for the nerve blocks in the study will include only ropivacaine 0.5% and
      lidocaine 1%. For subject sedation, midazolam and fentanyl will be used. None of these
      medications are considered study drugs; rather they are commonly used anesthetic medications.
      While used in the study, these drugs themselves are not being investigated. The same
      medications will be used on subjects not enrolled in the study.

      Study Treatment Group 1 - Saphenous nerve block using ultrasound guidance The needle will be
      placed with the needle tip in close proximity (1-2 mm) of the target structures (the
      saphenous nerve if visible or in the subsartorial facial plane of the sartorius muscle if the
      nerve is not visible). A total of 10 mL of 0.5% ropivacaine will be used for the block.
      Before injection of any local anesthetic a gentle aspiration will be preformed, with a second
      aspiration after 5 mL of ropivacaine has been injected. Once injection of local anesthetic
      has commenced small needle adjustments are allowed to enhance spread. This will be done at
      the discretion of the regional anesthesiologist performing the block.

      Study Treatment Group 2 - Saphenous nerve blockade using ultrasound guidance and nerve
      stimulation The needle will be place with the needle tip in close proximity (1-2 mm) of the
      target structure (the saphenous nerve if visible or in the subsartorial fascial plane if the
      nerve is not visible). The Pajunk MultiStim SENSOR nerve stimulator will then be turned on,
      starting at 1.0 milliamp (mA) until a tapping sensation is elicited in the medial or anterior
      aspect of the ankle. The amplitude of the nerve stimulator will then be gradually decreased
      with maintenance of the tapping sensation by making small adjustments in needle location. The
      end-point for nerve localization will be a tapping sensation in the area of the medial
      malleolus at ≤ 0.6 mA. The anesthesiologist will have a maximum search time of 5 minutes from
      needle entry to elicitation of the tapping sensation. Once a tapping sensation is elicited in
      the ≤ 0.6 mA range, 10 mL of 0.5% ropivacaine will be injected at the site. If a tapping
      sensation is elicited but not ≤ 0.6 mA within 5 minutes then 10 mL of 0.5% ropivacaine will
      be injected at the site where the lowest amplitude tapping sensation was elicited. If no
      tapping sensation is elicited from the subject after 5 minutes, an injection of 10 mL of
      ropivacaine will be made below the Sartorius muscle in the subsartorial fascial plane. Before
      injection of any local anesthetic a gentle aspiration will be preformed, with a second
      aspiration after 5 mL of ropivacaine has been injected. Once injection of local anesthetic
      has commenced small needle adjustments are allowed to enhance spread. This will be done at
      the discretion of the regional anesthesiologist performing the block.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Block Success</measure>
    <time_frame>30 minutes post nerve block</time_frame>
    <description>Complete absence of sensation to pinprick at two different anatomic areas of the saphenous nerve at thirty minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Block Failure Rate</measure>
    <time_frame>30 minutes post nerve block</time_frame>
    <description>Persistent sensation in the saphenous nerve distribution at 30 minutes (i.e., absence of any evidence of blockade [decreased or complete absence of sensation] at both areas: normal sensation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any Evidence of Blockade (Decreased or Complete Absence of Sensation)</measure>
    <time_frame>30 min</time_frame>
    <description>Participants with any evidence of blockade (decreased or complete absence of sensation) at the two different anatomic areas in the distribution of the saphenous nerve (2 cm proximal to the medial malleolus and 10 cm distal to the medial tibial condyle)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incomplete Block Rate</measure>
    <time_frame>30 minutes post nerve block</time_frame>
    <description>incomplete [decreased only] loss of sensation in the saphenous nerve distribution at 30 minutes at both areas of assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speed of Onset for Nerve Block (Complete Blockade)</measure>
    <time_frame>30 minutes post nerve block</time_frame>
    <description>Median (Kaplan-Meier curve &quot;survival&quot;) time required to reach complete absence of sensation to pinprick at the two different anatomic areas of assessment in the distribution of the saphenous nerve (2 cm proximal to the medial malleolus and 10 cm distal to the medial condyle of the tibia).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Success of Elicitation of a Tapping Sensation</measure>
    <time_frame>5 minutes</time_frame>
    <description>successful elicitation of any &quot;tapping&quot; sensation in the saphenous nerve distribution within the 5 min stimulation time limit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Minimum Stimulation Current</measure>
    <time_frame>5 minutes</time_frame>
    <description>the mean minimum stimulation current magnitude to elicit &quot;tapping&quot; sensation in the saphenous nerve distribution (cf. 3.2.3 below)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Success of Elicitation of a Tapping Sensation at &lt; 0.6 Milliampere (mA)</measure>
    <time_frame>5 minutes</time_frame>
    <description>Successful elicitation of &quot;tapping&quot; sensation in the saphenous nerve distribution at ≤ 0.6 mA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Required to Administer Block</measure>
    <time_frame>10 minutes</time_frame>
    <description>The time required for the block to be completed (from scanning to removal of needle)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate Complications</measure>
    <time_frame>60 minutes post block completion</time_frame>
    <description>Any complications as a result of block placement (e.g. local anesthetic toxicity, hematoma, pain etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed Complications</measure>
    <time_frame>7 days post operative</time_frame>
    <description>Any complication as a results of nerve block placement (e.g. persistent paresthesia, nerve injury)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Saphenous Nerve Block</condition>
  <arm_group>
    <arm_group_label>Ultrasound Guidance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Saphenous nerve block placed using ultrasound guidance alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound Guidance + nerve stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound Guidance</intervention_name>
    <description>Ultrasound guidance will be used to place a saphenous nerve block</description>
    <arm_group_label>Ultrasound Guidance</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound guidance + nerve stimulation</intervention_name>
    <description>Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
    <arm_group_label>Ultrasound Guidance + nerve stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects undergoing foot and ankle surgery

          2. Aged 19-80

          3. Normal sensation in saphenous nerve distribution in both legs

          4. Provided written informed consent.

          5. Body Mass Index &lt;38 kg/m2

        Exclusion Criteria:

          1. Subject refusal

          2. A known history of allergy, sensitivity or any other form of reaction to local
             anesthetics of amide type

          3. Suspected inability to comply with study procedures, including language difficulties
             or medical history and/or concomitant disease (i.e. skin infection as the site of
             needle insertion), as judged by the investigator. Reason for exclusion will be
             recorded.

          4. A neurological and/or vascular condition, which may preclude eligibility for
             peripheral nerve blockade (i.e. peripheral neuropathy) as judged by the investigator.
             Reason for exclusion will be recorded.

          5. Subjects on therapeutic anticoagulation or coagulopathy at the time of nerve blockade.

          6. Previous inclusion in this study.

          7. Participation in other clinical studies during this study or in the 14 days prior to
             admission to this study.

          8. Surgeon refusal (e.g. the surgeon does not want a nerve block for the subject). Reason
             for exclusion will be recorded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Bell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Tsui BC, Ozelsel T. Ultrasound-guided transsartorial perifemoral artery approach for saphenous nerve block. Reg Anesth Pain Med. 2009 Mar-Apr;34(2):177-8; author reply 178. doi: 10.1097/AAP.0b013e31819a273e.</citation>
    <PMID>19282716</PMID>
  </reference>
  <reference>
    <citation>Horn JL, Pitsch T, Salinas F, Benninger B. Anatomic basis to the ultrasound-guided approach for saphenous nerve blockade. Reg Anesth Pain Med. 2009 Sep-Oct;34(5):486-9. doi: 10.1097/AAP.0b013e3181ae11af.</citation>
    <PMID>19920424</PMID>
  </reference>
  <reference>
    <citation>López AM, Sala-Blanch X, Magaldi M, Poggio D, Asuncion J, Franco CD. Ultrasound-guided ankle block for forefoot surgery: the contribution of the saphenous nerve. Reg Anesth Pain Med. 2012 Sep-Oct;37(5):554-7. doi: 10.1097/AAP.0b013e3182611483.</citation>
    <PMID>22854395</PMID>
  </reference>
  <reference>
    <citation>Chen J, Lesser J, Hadzic A, Resta-Flarer F. The importance of the proximal saphenous nerve block for foot and ankle surgery. Reg Anesth Pain Med. 2013 Jul-Aug;38(4):372. doi: 10.1097/AAP.0b013e318295596a.</citation>
    <PMID>23788076</PMID>
  </reference>
  <reference>
    <citation>Head SJ, Leung RC, Hackman GP, Seib R, Rondi K, Schwarz SK. Ultrasound-guided saphenous nerve block--within versus distal to the adductor canal: a proof-of-principle randomized trial. Can J Anaesth. 2015 Jan;62(1):37-44. doi: 10.1007/s12630-014-0255-1. Epub 2014 Oct 22.</citation>
    <PMID>25337966</PMID>
  </reference>
  <reference>
    <citation>Benzon HT, Sharma S, Calimaran A. Comparison of the different approaches to saphenous nerve block. Anesthesiology. 2005 Mar;102(3):633-8.</citation>
    <PMID>15731603</PMID>
  </reference>
  <reference>
    <citation>Chi J, Greensmith JE. Saphenous nerve block technique with neurostimulation. Reg Anesth Pain Med. 2007 Nov-Dec;32(6):548-9.</citation>
    <PMID>18035315</PMID>
  </reference>
  <reference>
    <citation>Comfort VK, Lang SA, Yip RW. Saphenous nerve anaesthesia--a nerve stimulator technique. Can J Anaesth. 1996 Aug;43(8):852-7.</citation>
    <PMID>8840065</PMID>
  </reference>
  <reference>
    <citation>van der Wal M, Lang SA, Yip RW. Transsartorial approach for saphenous nerve block. Can J Anaesth. 1993 Jun;40(6):542-6.</citation>
    <PMID>8403121</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2015</study_first_posted>
  <results_first_submitted>July 26, 2016</results_first_submitted>
  <results_first_submitted_qc>September 6, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 2, 2018</results_first_posted>
  <last_update_submitted>September 6, 2017</last_update_submitted>
  <last_update_submitted_qc>September 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Scott Bell</investigator_full_name>
    <investigator_title>Dr. Scott Bell</investigator_title>
  </responsible_party>
  <keyword>Saphenous Nerve</keyword>
  <keyword>Nerve Block</keyword>
  <keyword>Ultrasound guided</keyword>
  <keyword>Neurostimulation</keyword>
  <keyword>Regional Anesthesia</keyword>
  <keyword>Ropivacaine</keyword>
  <keyword>Foot Surgery</keyword>
  <keyword>Nerve Stimulation</keyword>
  <keyword>Ankle Surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ultrasound Guidance</title>
          <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
        </group>
        <group group_id="P2">
          <title>Ultrasound Guidance and Nerve Stimulation</title>
          <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Allocated</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Analyzed</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ultrasound Guidance</title>
          <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
        </group>
        <group group_id="B2">
          <title>Ultrasound Guidance and Nerve Stimulation</title>
          <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50" spread="15"/>
                    <measurement group_id="B2" value="53" spread="14"/>
                    <measurement group_id="B3" value="52" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26" spread="3"/>
                    <measurement group_id="B2" value="25" spread="4"/>
                    <measurement group_id="B3" value="25" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>American Society of Anesthesiologists (ASA) physical status</title>
          <description>ASA I: A normal healthy patient ASA II: A patient with mild systemic disease ASA III: A patient with severe systemic disease ASA IV: A patient with severe systemic disease that is a constant threat to life ASA V: A moribund patient who is not expected to survive without the operation
(For reference, see https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system)</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>I or II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>III to V</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Type of surgery</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Foot/ankle joint reconstruction/fusion/arthrodesis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthroscopy/debridement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mass/hardware removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fracture fixation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tendon repair/transfer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Amputation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Block Success</title>
        <description>Complete absence of sensation to pinprick at two different anatomic areas of the saphenous nerve at thirty minutes</description>
        <time_frame>30 minutes post nerve block</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Block Success</title>
          <description>Complete absence of sensation to pinprick at two different anatomic areas of the saphenous nerve at thirty minutes</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We sought to detect an increase in the rate of complete absence of sensation to pinprick 30 min following ultrasound-guided subsartorial saphenous nerve blockade to 90% from an assumed baseline of 64% as extrapolated from our previous study (cf. Head SJ et al. 2015) at β = 0.2. The required minimum sample size at α = 0.05 (one-sided) was 30 patients in each group. To be conservative, we aimed to enroll a total of 80 patients.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.25</p_value>
            <p_value_desc>One-sided P-value based on the lack of plausibility that additional nerve stimulation would worsen sensory blockade rates.</p_value_desc>
            <method>Fisher Exact</method>
            <param_type>Difference between proportions (%)</param_type>
            <param_value>10.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-11.9</ci_lower_limit>
            <ci_upper_limit>31.9</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Block Failure Rate</title>
        <description>Persistent sensation in the saphenous nerve distribution at 30 minutes (i.e., absence of any evidence of blockade [decreased or complete absence of sensation] at both areas: normal sensation.</description>
        <time_frame>30 minutes post nerve block</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Block Failure Rate</title>
          <description>Persistent sensation in the saphenous nerve distribution at 30 minutes (i.e., absence of any evidence of blockade [decreased or complete absence of sensation] at both areas: normal sensation.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Normal sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decreased or no sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This contingency-table type analysis (Fisher Exact test) compares the two groups, &quot;Ultrasound Guidance&quot; and &quot;Ultrasound Guidance and Nerve Stimulation&quot;, as far as the two categorical outcomes are concerned, &quot;block failure at 30 minutes post nerve block&quot; versus &quot;no block failure at 30 minutes post nerve block&quot;.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.62</p_value>
            <p_value_desc>Two-sided P-value</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Evidence of Blockade (Decreased or Complete Absence of Sensation)</title>
        <description>Participants with any evidence of blockade (decreased or complete absence of sensation) at the two different anatomic areas in the distribution of the saphenous nerve (2 cm proximal to the medial malleolus and 10 cm distal to the medial tibial condyle)</description>
        <time_frame>30 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Any Evidence of Blockade (Decreased or Complete Absence of Sensation)</title>
          <description>Participants with any evidence of blockade (decreased or complete absence of sensation) at the two different anatomic areas in the distribution of the saphenous nerve (2 cm proximal to the medial malleolus and 10 cm distal to the medial tibial condyle)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.62</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incomplete Block Rate</title>
        <description>incomplete [decreased only] loss of sensation in the saphenous nerve distribution at 30 minutes at both areas of assessment</description>
        <time_frame>30 minutes post nerve block</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Incomplete Block Rate</title>
          <description>incomplete [decreased only] loss of sensation in the saphenous nerve distribution at 30 minutes at both areas of assessment</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Decreased sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal or no sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This contingency-table type analysis (Fisher Exact test) compares the two groups, &quot;Ultrasound Guidance&quot; and &quot;Ultrasound Guidance and Nerve Stimulation&quot;, as far as the two categorical outcomes are concerned, &quot;incomplete block at 30 minutes post nerve block&quot; versus &quot;no incomplete block at 30 minutes post nerve block&quot;.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.26</p_value>
            <p_value_desc>Two-sided P-value</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Speed of Onset for Nerve Block (Complete Blockade)</title>
        <description>Median (Kaplan-Meier curve &quot;survival&quot;) time required to reach complete absence of sensation to pinprick at the two different anatomic areas of assessment in the distribution of the saphenous nerve (2 cm proximal to the medial malleolus and 10 cm distal to the medial condyle of the tibia).</description>
        <time_frame>30 minutes post nerve block</time_frame>
        <population>Participants with complete absence of sensation to pinprick at the two different anatomic areas of assessment in the distribution of the saphenous nerve (2 cm proximal to the medial malleolus and 10 cm distal to the medial condyle of the tibia)</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Speed of Onset for Nerve Block (Complete Blockade)</title>
          <description>Median (Kaplan-Meier curve &quot;survival&quot;) time required to reach complete absence of sensation to pinprick at the two different anatomic areas of assessment in the distribution of the saphenous nerve (2 cm proximal to the medial malleolus and 10 cm distal to the medial condyle of the tibia).</description>
          <population>Participants with complete absence of sensation to pinprick at the two different anatomic areas of assessment in the distribution of the saphenous nerve (2 cm proximal to the medial malleolus and 10 cm distal to the medial condyle of the tibia)</population>
          <units>Minutes</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.0" lower_limit="20.0" upper_limit="30.0"/>
                    <measurement group_id="O2" value="17.5" lower_limit="15.0" upper_limit="25.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To assess speed of onset, sensation to pinprick in the distribution of the saphenous nerve was assessed for each patient every 5 min until complete sensory loss was noted, or until 30 min had elapsed. To compare the two groups in speed of onset on the basis of these data, we constructed Kaplan-Meyer &quot;survival&quot; curves for the times to onset of sensory blockade and compared the underlying time-to-event data with the log-rank test.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.12</p_value>
            <method>Log Rank</method>
            <param_type>&quot;Median survival&quot; ratio</param_type>
            <param_value>0.70</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.38</ci_lower_limit>
            <ci_upper_limit>1.31</ci_upper_limit>
            <estimate_desc>Numerator, group &quot;Ultrasound Guidance&quot;; denominator, group, &quot;Ultrasound Guidance + Nerve Stimulation&quot;</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Success of Elicitation of a Tapping Sensation</title>
        <description>successful elicitation of any “tapping” sensation in the saphenous nerve distribution within the 5 min stimulation time limit</description>
        <time_frame>5 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Success of Elicitation of a Tapping Sensation</title>
          <description>successful elicitation of any “tapping” sensation in the saphenous nerve distribution within the 5 min stimulation time limit</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Minimum Stimulation Current</title>
        <description>the mean minimum stimulation current magnitude to elicit “tapping” sensation in the saphenous nerve distribution (cf. 3.2.3 below)</description>
        <time_frame>5 minutes</time_frame>
        <population>Participants in the &quot;Ultrasound Guidance and nerve stimulation&quot; group with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Minimum Stimulation Current</title>
          <description>the mean minimum stimulation current magnitude to elicit “tapping” sensation in the saphenous nerve distribution (cf. 3.2.3 below)</description>
          <population>Participants in the &quot;Ultrasound Guidance and nerve stimulation&quot; group with available data</population>
          <units>mA</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" lower_limit="0.31" upper_limit="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Success of Elicitation of a Tapping Sensation at &lt; 0.6 Milliampere (mA)</title>
        <description>Successful elicitation of “tapping” sensation in the saphenous nerve distribution at ≤ 0.6 mA</description>
        <time_frame>5 minutes</time_frame>
        <population>Participants in the &quot;Ultrasound Guidance and nerve stimulation&quot; group with successful stimulation and available current magnitude data</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance and Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Success of Elicitation of a Tapping Sensation at &lt; 0.6 Milliampere (mA)</title>
          <description>Successful elicitation of “tapping” sensation in the saphenous nerve distribution at ≤ 0.6 mA</description>
          <population>Participants in the &quot;Ultrasound Guidance and nerve stimulation&quot; group with successful stimulation and available current magnitude data</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Required to Administer Block</title>
        <description>The time required for the block to be completed (from scanning to removal of needle)</description>
        <time_frame>10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Time Required to Administer Block</title>
          <description>The time required for the block to be completed (from scanning to removal of needle)</description>
          <units>s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="207" spread="76"/>
                    <measurement group_id="O2" value="314" spread="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Difference between means (s)</param_type>
            <param_value>107</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>61</ci_lower_limit>
            <ci_upper_limit>153</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Immediate Complications</title>
        <description>Any complications as a result of block placement (e.g. local anesthetic toxicity, hematoma, pain etc.)</description>
        <time_frame>60 minutes post block completion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Immediate Complications</title>
          <description>Any complications as a result of block placement (e.g. local anesthetic toxicity, hematoma, pain etc.)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Local anesthetic systemic toxicity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain on needle manipulation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paresthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive aspiration (of blood)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pruritus of the blocked leg in saph. n. distrib.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Transient increase in pain in medial malleolus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Delayed Complications</title>
        <description>Any complication as a results of nerve block placement (e.g. persistent paresthesia, nerve injury)</description>
        <time_frame>7 days post operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Delayed Complications</title>
          <description>Any complication as a results of nerve block placement (e.g. persistent paresthesia, nerve injury)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Paresthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Speed of Onset for Any Blockade in the Area 2 cm Proximal to the Medial Malleolus Only</title>
        <description>Median (Kaplan-Meier curve &quot;survival&quot;) time required to reach any evidence of sensory blockade (decreased or complete absence of sensation) in the area 2 cm proximal to the medial malleolus only</description>
        <time_frame>30 min</time_frame>
        <population>Participants with any evidence of sensory blockade (decreased or complete absence of sensation) in the area 2 cm proximal to the medial malleolus only</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Speed of Onset for Any Blockade in the Area 2 cm Proximal to the Medial Malleolus Only</title>
          <description>Median (Kaplan-Meier curve &quot;survival&quot;) time required to reach any evidence of sensory blockade (decreased or complete absence of sensation) in the area 2 cm proximal to the medial malleolus only</description>
          <population>Participants with any evidence of sensory blockade (decreased or complete absence of sensation) in the area 2 cm proximal to the medial malleolus only</population>
          <units>Minutes</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.0" lower_limit="20.0" upper_limit="30.0"/>
                    <measurement group_id="O2" value="17.5" lower_limit="15.0" upper_limit="25.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Log Rank</method>
            <param_type>&quot;Median survival&quot; ratio</param_type>
            <param_value>0.58</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.37</ci_lower_limit>
            <ci_upper_limit>0.93</ci_upper_limit>
            <estimate_desc>Numerator, group &quot;Ultrasound Guidance&quot;; denominator, group, &quot;Ultrasound Guidance + Nerve Stimulation&quot;</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Sensory Blockade Scores by Individual Assessment Area: Medial Malleolus</title>
        <description>Sensation to pinprick with an 18 gauge blunt needle was assessed individually at the two different anatomic areas in the distribution of the saphenous nerve: Here, the results are reported for the area 2 cm proximal to the medial malleolus only</description>
        <time_frame>30 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Sensory Blockade Scores by Individual Assessment Area: Medial Malleolus</title>
          <description>Sensation to pinprick with an 18 gauge blunt needle was assessed individually at the two different anatomic areas in the distribution of the saphenous nerve: Here, the results are reported for the area 2 cm proximal to the medial malleolus only</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>2 = absent sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 = decreased sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0 = normal sensation (no block)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Sensory Blockade Scores by Individual Assessment Area: Medial Tibial Condyle</title>
        <description>Sensation to pinprick with an 18 gauge blunt needle was assessed individually at the two different anatomic areas in the distribution of the saphenous nerve: Here, the results are reported for the area 10 cm distal to the medial tibial condyle only</description>
        <time_frame>30 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guidance</title>
            <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Guidance + Nerve Stimulation</title>
            <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
          </group>
        </group_list>
        <measure>
          <title>Sensory Blockade Scores by Individual Assessment Area: Medial Tibial Condyle</title>
          <description>Sensation to pinprick with an 18 gauge blunt needle was assessed individually at the two different anatomic areas in the distribution of the saphenous nerve: Here, the results are reported for the area 10 cm distal to the medial tibial condyle only</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>2 = absent sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 = decreased sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0 = normal sensation (no block)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Response Versus Lack of Response to Nerve Stimulation and Block Failure Rate</title>
        <description>Percentage of block failure (persistent sensation in the saphenous nerve distribution at 30 minutes -- i.e., absence of any evidence of blockade [decreased or complete absence of sensation] at both areas: normal sensation) among participants in the Ultrasound Guidance and Nerve Stimulation group with response versus no response to nerve stimulation</description>
        <time_frame>30 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Responders to Nerve Stimulation</title>
            <description>Participants in the Ultrasound Guidance and Nerve Stimulation group with response to nerve stimulation</description>
          </group>
          <group group_id="O2">
            <title>Non-responders to Nerve Stimulation</title>
            <description>participants in the Ultrasound Guidance and Nerve Stimulation group with no response to nerve stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Response Versus Lack of Response to Nerve Stimulation and Block Failure Rate</title>
          <description>Percentage of block failure (persistent sensation in the saphenous nerve distribution at 30 minutes -- i.e., absence of any evidence of blockade [decreased or complete absence of sensation] at both areas: normal sensation) among participants in the Ultrasound Guidance and Nerve Stimulation group with response versus no response to nerve stimulation</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Block failure (normal sensation)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No block failure (decreased or no sensation)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This contingency-table type analysis (Fisher Exact test) compares the two arms, &quot;Patients with response to nerve stimulation&quot; and &quot;Patients with lack response to nerve stimulation&quot;, as far as the two categorical outcomes are concerned, &quot;block failure at 30 minutes post nerve block&quot; versus &quot;no block failure at 30 minutes post nerve block&quot;.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0057</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected immediately (i.e., on the day of the intervention/postoperative day 0); on postoperative days 2 and 7, patients were contacted via telephone to enquire about the presence of any delayed complications. In case of presence of any delayed complications at the day 7 follow-up, patients were to be contacted every 7 days until symptom resolution, and further investigations and/or management were to be provided at this time.</time_frame>
      <desc>As noted above, all patients were systematically followed up via telephone to enquire about the presence of any delayed complications/adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Ultrasound Guidance</title>
          <description>Saphenous nerve block placed using ultrasound guidance alone
Ultrasound Guidance: Ultrasound guidance will be used to place a saphenous nerve block</description>
        </group>
        <group group_id="E2">
          <title>Ultrasound Guidance and Nerve Stimulation</title>
          <description>Saphenous nerve block placed using ultrasound guidance and nerve stimulation
Ultrasound guidance and nerve stimulation: Ultrasound guidance and nerve stimulation will be used to place a saphenous nerve block</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Paresthesia (on regional nerve block needle manpulation/advancement)</sub_title>
                <description>Common localized event during regional anesthesia (traditionally deliberately sought for nerve localization); transient and reversible.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Stephan Schwarz, Director of Research</name_or_title>
      <organization>Department of Anesthesia, St. Paul's Hospital/Providence Health Care</organization>
      <phone>(604) 806-8337</phone>
      <email>stephan.schwarz@ubc.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

